Medical News

RSS

Self-sealing sleeve for wound protection

As the days get longer and temperatures rise, so do incidences of outdoor-related injuries.

30 Apr 2010

MicroStockProfit.com releases investment report featuring Cardium Therapeutics

MicroStockProfit.com announces an investment report featuring Cardium Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

30 Apr 2010

BioScrip reports net loss of $7.2M on revenues of $335.1M for first-quarter 2010

BioScrip, Inc. today announced a first quarter net loss of $7.2 million, or $0.18 per share on revenues of $335.1 million. These results compare to net income of $3.3 million, or $0.08 per share, on revenues of $325.7 million for the first quarter of 2009.

30 Apr 2010

REGN reports net loss of $30.5M for first-quarter 2010

Regeneron Pharmaceuticals, Inc. announced financial and operating results for the first quarter of 2010. The Company reported a net loss of $30.5 million, or $0.38 per share (basic and diluted), for the first quarter of 2010 compared with a net loss of $15.4 million, or $0.19 per share (basic and diluted), for the first quarter of 2009.

30 Apr 2010

Repros Therapeutics receives FDA guidance for lifting clinical hold status of Proellex

Repros Therapeutics Inc. today announced that a teleconference was held with the FDA to review the clinical hold status of Proellex®. Previously clinical studies were stopped due to findings of changes in liver enzymes at higher doses of the oral drug resulting in serious adverse events. Proellex is being studied as a treatment for uterine fibroids and endometriosis.

30 Apr 2010

Whole-genome analysis may play future role in clinical medicine: Study

Scientists at Stanford and Harvard Universities collaborated to assess the clinical usefulness of analyzing a patient's full genome for disease risks and unusual drug responses. The work brings closer to reality the concept that whole-genome sequencing might one day play a clinical role.

30 Apr 2010

Magellan Health Services reports net revenue of $728.1M for first-quarter ended March 31, 2010

Magellan Health Services, Inc. today reported net revenue of $728.1 million, net income of $25.5 million or $0.73 per diluted common share, and segment profit, representing income from continuing operations before stock compensation expense, depreciation and amortization, interest expense, interest income, gain on sale of assets, special charges or benefits, and income taxes, of $61.4 million for the quarter ended March 31, 2010.

30 Apr 2010

NLV Partners closes second tranche of $26 million Series D financing in Oxford Immunotec

New Leaf Venture Partners (NLV Partners) announced today the closing of the second tranche of a $26 million investment in Oxford Immunotec Ltd., a leading manufacturer and marketer of T cell-based diagnostic tests. The Series D financing was led by NLV Partners, and additional participants included new investor Kaiser Permanente Ventures and existing investors Clarus Ventures, Wellington Partners, Kuwait-based National Technology Enterprises Company, SPARK Ventures, DFJ Esprit, Oxford University and The Dow Chemical Company.

30 Apr 2010

New PCA-Rx therapy provides natural toxin removal treatment to Alzheimer's patients

According to the Alzheimer's Association, over 5 million Americans are afflicted with Alzheimer's disease. While its cause is controversial, many people believe a correlation exists with toxin accumulation. Until recently, chelation, an invasive, drug-based toxin removal therapy, has been patients' primary option.

30 Apr 2010

Coventry Health Care reports net earnings of $97.3 million for first-quarter 2010

Coventry Health Care, Inc. today reported consolidated operating results for the quarter ended March 31, 2010. Operating revenues totaled $2.9 billion for the quarter with net earnings of $97.3 million, or $0.66 earnings per diluted share (EPS). Excluding the favorable impact of Medicare Advantage Private Fee-for-Service (MA-PFFS) results in the quarter, operating revenues totaled $2.9 billion for the quarter with net earnings of $71.9 million, or $0.49 EPS.

30 Apr 2010

Amerigroup reports net income of $42.2M for first-quarter 2010

Amerigroup Corporation today announced that net income for the first quarter of 2010 was $42.2 million, or $0.82 per diluted share, versus $40.2 million, or $0.79 per diluted share, for the fourth quarter of 2009.

30 Apr 2010

Acorda Therapeutics reports AMPYRA gross sales of $3.4 million for first-quarter 2010

Acorda Therapeutics, Inc. today announced its financial results for the first quarter of 2010.

30 Apr 2010

Accurate reporting of errors can reduce preventable hospital deaths: SIOP

People go to hospitals to be treated for an illness or for corrective surgery with the expectation they will return home in much better health than when they entered the medical facility.

30 Apr 2010

Excess urinary protein excretion increases risk of kidney, heart complications in people with hypertension

Healthy people with high blood pressure who excrete a slight excess of protein in the urine raise their risk of developing kidney and heart complications. According to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN), more attention should focus on the potential health effects of urinary protein excretion in individuals with high blood pressure (hypertension).

30 Apr 2010

Jumping elements in primates may have important consequences for studies of human genetic diseases

The density of transposable (jumping) elements between sex chromosomes in primates may have important consequences for the studies of human genetic diseases, say Penn State University researchers.

30 Apr 2010

Manipulating physiology of "kissing bug" may help prevent transmission of Chagas' disease

It makes your skin crawl-a bug that crawls onto your lips while you sleep, drawn by the exhaled carbon dioxide, numbs your skin, bites, then gorges on your blood. And if that's not insult enough, it promptly defecates on the wound-and passes on a potentially deadly disease.

30 Apr 2010

Nationwide Children's Hospital opens first pediatric Pseudotumor Cerebri Clinic in the U.S.

While most headaches in children can be treated with over-the-counter pain medications or lifestyle changes, it is important to pay attention to their symptoms in case they herald something more serious.

30 Apr 2010

G8 development ministers agree on 'guiding principles' for child and maternal health initiative

G8 development ministers "agreed to a set of guiding principles [for Canada's G8 maternal and child health initiative] that leaves flexibility for countries to 'build their basket of initiatives,'" Bev Oda, the Canadian minister for international cooperation, said at a closing news conference on Wednesday, the Toronto Star reports.

30 Apr 2010

CDC report shows increase in seasonal flu vaccinations, greatest increase among children

More Americans were vaccinated against seasonal flu during the 2009-10 season (40 percent of eligible population) than during the previous flu season (33 percent of eligible population), according to a report by the Centers for Disease Control and Prevention.

30 Apr 2010

Study confirms MammaPrint's capabilities in determining patients likely to benefit from chemotherapy

Today, at the 11th Annual Meeting of the American Society of Breast Surgeons, Agendia, a world leader in molecular cancer diagnostics, announced that Breast Cancer Research and Treatment has published an important study demonstrating the benefit of adjuvant chemotherapy for patients with a high-risk of breast cancer recurrence according to the MammaPrint test. The ASBS meeting takes places April 28 - May 2, 2010, at the Bellagio in Las Vegas, where you can meet the Agendia team at booth # 314.

30 Apr 2010

Medical News

Self-sealing sleeve for wound protection

MicroStockProfit.com releases investment report featuring Cardium Therapeutics

BioScrip reports net loss of $7.2M on revenues of $335.1M for first-quarter 2010

REGN reports net loss of $30.5M for first-quarter 2010

Repros Therapeutics receives FDA guidance for lifting clinical hold status of Proellex

Whole-genome analysis may play future role in clinical medicine: Study

Magellan Health Services reports net revenue of $728.1M for first-quarter ended March 31, 2010

NLV Partners closes second tranche of $26 million Series D financing in Oxford Immunotec

New PCA-Rx therapy provides natural toxin removal treatment to Alzheimer's patients

Coventry Health Care reports net earnings of $97.3 million for first-quarter 2010

Amerigroup reports net income of $42.2M for first-quarter 2010

Acorda Therapeutics reports AMPYRA gross sales of $3.4 million for first-quarter 2010

Accurate reporting of errors can reduce preventable hospital deaths: SIOP

Excess urinary protein excretion increases risk of kidney, heart complications in people with hypertension

Jumping elements in primates may have important consequences for studies of human genetic diseases

Manipulating physiology of "kissing bug" may help prevent transmission of Chagas' disease

Nationwide Children's Hospital opens first pediatric Pseudotumor Cerebri Clinic in the U.S.

G8 development ministers agree on 'guiding principles' for child and maternal health initiative

CDC report shows increase in seasonal flu vaccinations, greatest increase among children

Study confirms MammaPrint's capabilities in determining patients likely to benefit from chemotherapy

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News